Hosted on MSN

Organon wins FDA nod to expand use of Nexplanon birth control implant

The U.S. Food and Drug Administration (FDA) has approved a label expansion for Nexplanon to allow its manufacturer, Organon (OGN), to market the birth control implant, indicating an efficacy duration ...
Zacks Investment Research on MSN

Organon secures FDA approval extending NEXPLANON use to five years

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five ...
Neurology Advisor

Nexplanon Approved for Pregnancy Prevention for Up to 5 Years

The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
MM&M

This Organon campaign for birth control jumps into BookTok’s ‘romantasy’ craze

Thanks to the corner of TikTok dubbed “BookTok,” fantasy and science fiction books have recently seen a boost in popularity — and pharma marketers are taking notice. Fantasy and science fiction book ...